Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPIPROP: Ibuprofen or Ketorolac with Caffeine for ROP Prevention
NCT02344225Phase 2Completed
- Sponsor
- SUNY Downstate Health Sciences University
- Start
- Jan 2015
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibuprofen, ketorolac tromethamine in retinopathy of prematurity (ROP), sponsored by SUNY Downstate Health Sciences University. Started Jan 2015; status: completed.
02
Drugs
ibuprofenketorolac tromethamine
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on NCT02344225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02344225.